Evid Invest

Earnings calendar/CILJF

China Life Insurance Company Limited (CILJF)

Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.

Financial statementsValuation

Pre-earnings

Consensus targets for the next print, plus how the business has been running.

Next report

Aug 26, 2026

Consensus estimate row

EPS target

$0.20

Street estimate

Revenue target

$82.99B

Street estimate

Trailing EPS (avg 4Q)

$0.22

Beat rate last 4: 25%

Latest EPS YoY

-28.4%

vs 2025-03-25

Latest revenue YoY

+55.8%

How results look so far

Trailing revenue (avg 4Q)

$15.19B

Printed quarters

EPS beat rate (4Q)

25%

Share of quarters that beat EPS est.

Post-earnings

Did the company hit the target? Actual vs estimate and surprise.

Last print

Apr 27, 2026

Reported

EPS actual / est

$0.10 / —

—

Revenue actual / est

$13.10B / —

—

Result

—

Based on EPS vs consensus

Earnings history

Estimate vs actual and surprise % by print date

DateEPS estEPS actEPS surpriseRev estRev actRev surprise
8/28/2026upcoming$0.20Pending—$83.02BPending—
8/26/2026upcoming$0.20Pending—$82.99BPending—
4/27/2026—$0.10——$13.10B—
3/26/2026upcoming$0.67Pending—$14.45BPending—
3/25/2026$0.53$0.57+8.3%$26.13B$29.28B+12.1%
8/27/2025$0.20$0.06-70.6%$22.16B$10.00B-54.9%
3/25/2025$0.33$0.14-57.7%$24.97B$8.40B-66.3%
12/31/2024—$0.01——$7.49B—
10/30/2024—$0.33——$27.17B—
8/29/2024$0.13$0.09-35.6%$67.35B$12.50B-81.4%
4/26/2024$-0.02$0.10+651.9%$23.20B$11.98B-48.4%
2/8/2024—$0.02——$17.52B—
9/30/2023—$-0.10——$72.77B—
8/23/2023$0.13$0.04-66.1%$61.53B$9.90B-83.9%
4/27/2023—$0.09——$53.26B—
4/21/2023$0.08$0.01-93.7%$25.29B$15.11B-40.3%
10/27/2022—$0.03——$25.79B—
6/30/2022$0.14$0.05-61.7%$62.92B$26.09B-58.5%
4/27/2022$0.09$0.09+2.2%$28.30B$53.78B+90.1%
12/31/2021—$0.01——$20.21B—
10/28/2021—$0.04——$27.35B—
6/30/2021$0.17$0.07-59.8%$68.69B$26.09B-62.0%
4/28/2021$0.14$0.15+10.8%$31.70B$57.45B+81.2%
12/31/2020—$0.02——$6.65B—
10/28/2020—$0.09——$25.77B—
6/30/2020$0.15$0.02-85.6%$59.59B$10.08B-83.1%
4/24/2020$0.10$0.08-19.3%$27.74B$46.54B+67.7%
12/31/2019—$0.02——$5.77B—
10/29/2019—$0.10——$22.28B—
6/30/2019—$0.03——$9.36B—
4/11/2019—$0.14——$44.17B—
12/31/2018—$-0.05——$13.02B—
10/25/2018—$0.02——$18.40B—
6/30/2018—$0.01——$19.68B—
4/11/2018—$0.08——$28.10B—
12/31/2017—$0.03——$14.53B—
10/26/2017—$0.08——$21.97B—
6/30/2017—$0.03——$18.31B—
4/11/2017—$0.03——$39.45B—
12/31/2016—$0.03——$12.13B—
10/27/2016—$0.02——$17.36B—
6/30/2016—$0.03——$17.71B—
4/11/2016—$0.03——$33.99B—
12/31/2015—$0.00——$12.85B—
10/28/2015—$0.01——$14.25B—
6/30/2015—$0.11——$22.36B—
4/9/2015—$0.07——$31.14B—
12/31/2014—$0.03——$15.20B—
10/28/2014—$0.05——$12.52B—
6/30/2014—$0.06——$13.98B—
4/10/2014—$0.04——$24.84B—
12/31/2013—$0.01——$11.05B—
10/25/2013—$0.04——$15.85B—
8/28/2013—$0.03——$17.74B—
4/19/2013—$0.06——$22.25B—
12/31/2012—$0.02——$8.09B—
10/26/2012—$-0.01——$15.12B—
8/28/2012—$0.02——$12.06B—
4/6/2012—$0.03——$20.93B—
12/31/2011—$0.01——$8.82B—
10/28/2011—$0.02——$12.97B—
8/23/2011—$0.03——$13.52B—
4/11/2011—$0.04——$21.37B—
12/31/2010—$0.05——$12.14B—
10/29/2010—$0.04——$13.29B—
6/30/2010—$0.04——$12.78B—
4/29/2010—$0.07——$7.62B—
4/8/2010—$0.05——$18.85B—
9/30/2009—$0.03——$11.55B—
6/30/2009—$0.07——$598.5M—
4/28/2009—$0.04——$-16.59B—
3/31/2009—$0.03——$16.97B—
9/30/2008—$0.01——$11.22B—
6/30/2008—$0.07——$-1.71B—
4/25/2008—$0.04——$5.83B—
3/31/2008—$0.02——$15.79B—
9/30/2007—$0.04——$5.97B—
6/30/2007—$0.05——$6.68B—
5/18/2007—$0.04——$13.14B—
3/31/2007—$0.05——$6.56B—
9/30/2006—$0.03——$2.83B—
6/30/2006—$0.02——$4.55B—
5/30/2006—$0.01——$3.18B—
3/31/2006—$0.02——$3.38B—
9/30/2005—$0.01——$3.04B—
8/30/2005—$0.01——$2.97B—
5/27/2005—$0.01——$2.32B—
3/31/2005—$0.01——$2.97B—
9/30/2004—$0.01——$2.32B—
6/30/2004—$0.01——$2.32B—
6/28/2004—$-0.00——$2.38B—
4/23/2004—$0.01——$2.32B—
9/30/2003—$-0.00——$2.38B—
6/30/2003—$-0.00——$2.38B—
3/31/2003—$-0.00——$2.38B—
EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.